0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Nucleic Acid Drug Raw Materials Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-27Y12520
Home | Market Reports | Science| Biological Sciences
Global Nucleic Acid Drug Raw Materials Market Research Report 2022
BUY CHAPTERS

Global Nucleic Acid Drug Raw Materials Market Research Report 2025

Code: QYRE-Auto-27Y12520
Report
February 2025
Pages:104
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Nucleic Acid Drug Raw Materials Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Nucleic Acid Drug Raw Materials Market

Nucleic Acid Drug Raw Materials Market

The global market for Nucleic Acid Drug Raw Materials was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Nucleic Acid Drug Raw Materials utilize nucleic acid, which refer to substances such as DNA and RNA that control genetic information, as drugs. These allow targeting of molecules such as mRNA and miRNA that cannot be targeted with traditional low molecular weight drugs and antibody medicines, and there is a great expectation for these drugs as next generation pharmaceuticals. Active research is being conducted globally as it is expected to lead to the creation of drugs which were previously intractable.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The market for nucleic acid drug raw materials is experiencing steady growth, driven by ongoing innovations in biotechnology and the pharmaceutical sector. The market size is gradually expanding, with increasing sales. Nucleic acid drug raw materials have specific uses in areas such as gene therapy, vaccine development, and personalized medicine, finding wide application in disease diagnosis and treatment. The future development prospects are promising, as nucleic acid drug raw materials are expected to continue playing a significant role in the pharmaceutical field, fostering industry innovation and evolution, fueled by technological advancements and growing medical demands.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nucleic Acid Drug Raw Materials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nucleic Acid Drug Raw Materials.
The Nucleic Acid Drug Raw Materials market size, estimations, and forecasts are provided in terms of output/shipments (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nucleic Acid Drug Raw Materials market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Nucleic Acid Drug Raw Materials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Nucleic Acid Drug Raw Materials Market Report

Report Metric Details
Report Name Nucleic Acid Drug Raw Materials Market
CAGR 5%
by Type
by Application
  • Research
  • Pharmaceutical
  • Other
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Danaher Corporation, Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Kaneka Eurogentec, GeneDesign, LGC Biosearch Technologies, Bio-synthesis, Guangzhou RiboBio, STA Pharmaceutical, Hongene Biotech
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Nucleic Acid Drug Raw Materials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Nucleic Acid Drug Raw Materials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Nucleic Acid Drug Raw Materials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Nucleic Acid Drug Raw Materials Market report?

Ans: The main players in the Nucleic Acid Drug Raw Materials Market are Danaher Corporation, Merck, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, GE Healthcare, Kaneka Eurogentec, GeneDesign, LGC Biosearch Technologies, Bio-synthesis, Guangzhou RiboBio, STA Pharmaceutical, Hongene Biotech

What are the Application segmentation covered in the Nucleic Acid Drug Raw Materials Market report?

Ans: The Applications covered in the Nucleic Acid Drug Raw Materials Market report are Research, Pharmaceutical, Other

What are the Type segmentation covered in the Nucleic Acid Drug Raw Materials Market report?

Ans: The Types covered in the Nucleic Acid Drug Raw Materials Market report are ASO, siRNA, Other

Recommended Reports

Pharmaceutical Raw Materials

Gene And RNA Therapies

Pharmaceutical Testing And Diagnostics

1 Nucleic Acid Drug Raw Materials Market Overview
1.1 Product Definition
1.2 Nucleic Acid Drug Raw Materials by Type
1.2.1 Global Nucleic Acid Drug Raw Materials Market Value Growth Rate Analysis by Type: 2024 VS 2031
1.2.2 ASO
1.2.3 siRNA
1.2.4 Other
1.3 Nucleic Acid Drug Raw Materials by Application
1.3.1 Global Nucleic Acid Drug Raw Materials Market Value Growth Rate Analysis by Application: 2024 VS 2031
1.3.2 Research
1.3.3 Pharmaceutical
1.3.4 Other
1.4 Global Market Growth Prospects
1.4.1 Global Nucleic Acid Drug Raw Materials Production Value Estimates and Forecasts (2020-2031)
1.4.2 Global Nucleic Acid Drug Raw Materials Production Capacity Estimates and Forecasts (2020-2031)
1.4.3 Global Nucleic Acid Drug Raw Materials Production Estimates and Forecasts (2020-2031)
1.4.4 Global Nucleic Acid Drug Raw Materials Market Average Price Estimates and Forecasts (2020-2031)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Nucleic Acid Drug Raw Materials Production Market Share by Manufacturers (2020-2025)
2.2 Global Nucleic Acid Drug Raw Materials Production Value Market Share by Manufacturers (2020-2025)
2.3 Global Key Players of Nucleic Acid Drug Raw Materials, Industry Ranking, 2023 VS 2024
2.4 Global Nucleic Acid Drug Raw Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Nucleic Acid Drug Raw Materials Average Price by Manufacturers (2020-2025)
2.6 Global Key Manufacturers of Nucleic Acid Drug Raw Materials, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Nucleic Acid Drug Raw Materials, Product Offered and Application
2.8 Global Key Manufacturers of Nucleic Acid Drug Raw Materials, Date of Enter into This Industry
2.9 Nucleic Acid Drug Raw Materials Market Competitive Situation and Trends
2.9.1 Nucleic Acid Drug Raw Materials Market Concentration Rate
2.9.2 Global 5 and 10 Largest Nucleic Acid Drug Raw Materials Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Nucleic Acid Drug Raw Materials Production by Region
3.1 Global Nucleic Acid Drug Raw Materials Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.2 Global Nucleic Acid Drug Raw Materials Production Value by Region (2020-2031)
3.2.1 Global Nucleic Acid Drug Raw Materials Production Value by Region (2020-2025)
3.2.2 Global Forecasted Production Value of Nucleic Acid Drug Raw Materials by Region (2026-2031)
3.3 Global Nucleic Acid Drug Raw Materials Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
3.4 Global Nucleic Acid Drug Raw Materials Production Volume by Region (2020-2031)
3.4.1 Global Nucleic Acid Drug Raw Materials Production by Region (2020-2025)
3.4.2 Global Forecasted Production of Nucleic Acid Drug Raw Materials by Region (2026-2031)
3.5 Global Nucleic Acid Drug Raw Materials Market Price Analysis by Region (2020-2025)
3.6 Global Nucleic Acid Drug Raw Materials Production and Value, Year-over-Year Growth
3.6.1 North America Nucleic Acid Drug Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.2 Europe Nucleic Acid Drug Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.3 China Nucleic Acid Drug Raw Materials Production Value Estimates and Forecasts (2020-2031)
3.6.4 Japan Nucleic Acid Drug Raw Materials Production Value Estimates and Forecasts (2020-2031)
4 Nucleic Acid Drug Raw Materials Consumption by Region
4.1 Global Nucleic Acid Drug Raw Materials Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
4.2 Global Nucleic Acid Drug Raw Materials Consumption by Region (2020-2031)
4.2.1 Global Nucleic Acid Drug Raw Materials Consumption by Region (2020-2025)
4.2.2 Global Nucleic Acid Drug Raw Materials Forecasted Consumption by Region (2026-2031)
4.3 North America
4.3.1 North America Nucleic Acid Drug Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.3.2 North America Nucleic Acid Drug Raw Materials Consumption by Country (2020-2031)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Nucleic Acid Drug Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.4.2 Europe Nucleic Acid Drug Raw Materials Consumption by Country (2020-2031)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Nucleic Acid Drug Raw Materials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031
4.5.2 Asia Pacific Nucleic Acid Drug Raw Materials Consumption by Region (2020-2031)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
4.6.2 Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption by Country (2020-2031)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Nucleic Acid Drug Raw Materials Production by Type (2020-2031)
5.1.1 Global Nucleic Acid Drug Raw Materials Production by Type (2020-2025)
5.1.2 Global Nucleic Acid Drug Raw Materials Production by Type (2026-2031)
5.1.3 Global Nucleic Acid Drug Raw Materials Production Market Share by Type (2020-2031)
5.2 Global Nucleic Acid Drug Raw Materials Production Value by Type (2020-2031)
5.2.1 Global Nucleic Acid Drug Raw Materials Production Value by Type (2020-2025)
5.2.2 Global Nucleic Acid Drug Raw Materials Production Value by Type (2026-2031)
5.2.3 Global Nucleic Acid Drug Raw Materials Production Value Market Share by Type (2020-2031)
5.3 Global Nucleic Acid Drug Raw Materials Price by Type (2020-2031)
6 Segment by Application
6.1 Global Nucleic Acid Drug Raw Materials Production by Application (2020-2031)
6.1.1 Global Nucleic Acid Drug Raw Materials Production by Application (2020-2025)
6.1.2 Global Nucleic Acid Drug Raw Materials Production by Application (2026-2031)
6.1.3 Global Nucleic Acid Drug Raw Materials Production Market Share by Application (2020-2031)
6.2 Global Nucleic Acid Drug Raw Materials Production Value by Application (2020-2031)
6.2.1 Global Nucleic Acid Drug Raw Materials Production Value by Application (2020-2025)
6.2.2 Global Nucleic Acid Drug Raw Materials Production Value by Application (2026-2031)
6.2.3 Global Nucleic Acid Drug Raw Materials Production Value Market Share by Application (2020-2031)
6.3 Global Nucleic Acid Drug Raw Materials Price by Application (2020-2031)
7 Key Companies Profiled
7.1 Danaher Corporation
7.1.1 Danaher Corporation Nucleic Acid Drug Raw Materials Company Information
7.1.2 Danaher Corporation Nucleic Acid Drug Raw Materials Product Portfolio
7.1.3 Danaher Corporation Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.1.4 Danaher Corporation Main Business and Markets Served
7.1.5 Danaher Corporation Recent Developments/Updates
7.2 Merck
7.2.1 Merck Nucleic Acid Drug Raw Materials Company Information
7.2.2 Merck Nucleic Acid Drug Raw Materials Product Portfolio
7.2.3 Merck Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.2.4 Merck Main Business and Markets Served
7.2.5 Merck Recent Developments/Updates
7.3 Eurofins Scientific
7.3.1 Eurofins Scientific Nucleic Acid Drug Raw Materials Company Information
7.3.2 Eurofins Scientific Nucleic Acid Drug Raw Materials Product Portfolio
7.3.3 Eurofins Scientific Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.3.4 Eurofins Scientific Main Business and Markets Served
7.3.5 Eurofins Scientific Recent Developments/Updates
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Company Information
7.4.2 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Product Portfolio
7.4.3 Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.4.4 Thermo Fisher Scientific Main Business and Markets Served
7.4.5 Thermo Fisher Scientific Recent Developments/Updates
7.5 Agilent Technologies
7.5.1 Agilent Technologies Nucleic Acid Drug Raw Materials Company Information
7.5.2 Agilent Technologies Nucleic Acid Drug Raw Materials Product Portfolio
7.5.3 Agilent Technologies Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.5.4 Agilent Technologies Main Business and Markets Served
7.5.5 Agilent Technologies Recent Developments/Updates
7.6 GE Healthcare
7.6.1 GE Healthcare Nucleic Acid Drug Raw Materials Company Information
7.6.2 GE Healthcare Nucleic Acid Drug Raw Materials Product Portfolio
7.6.3 GE Healthcare Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.6.4 GE Healthcare Main Business and Markets Served
7.6.5 GE Healthcare Recent Developments/Updates
7.7 Kaneka Eurogentec
7.7.1 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Company Information
7.7.2 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Product Portfolio
7.7.3 Kaneka Eurogentec Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.7.4 Kaneka Eurogentec Main Business and Markets Served
7.7.5 Kaneka Eurogentec Recent Developments/Updates
7.8 GeneDesign
7.8.1 GeneDesign Nucleic Acid Drug Raw Materials Company Information
7.8.2 GeneDesign Nucleic Acid Drug Raw Materials Product Portfolio
7.8.3 GeneDesign Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.8.4 GeneDesign Main Business and Markets Served
7.8.5 GeneDesign Recent Developments/Updates
7.9 LGC Biosearch Technologies
7.9.1 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Company Information
7.9.2 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Product Portfolio
7.9.3 LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.9.4 LGC Biosearch Technologies Main Business and Markets Served
7.9.5 LGC Biosearch Technologies Recent Developments/Updates
7.10 Bio-synthesis
7.10.1 Bio-synthesis Nucleic Acid Drug Raw Materials Company Information
7.10.2 Bio-synthesis Nucleic Acid Drug Raw Materials Product Portfolio
7.10.3 Bio-synthesis Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.10.4 Bio-synthesis Main Business and Markets Served
7.10.5 Bio-synthesis Recent Developments/Updates
7.11 Guangzhou RiboBio
7.11.1 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Company Information
7.11.2 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Product Portfolio
7.11.3 Guangzhou RiboBio Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.11.4 Guangzhou RiboBio Main Business and Markets Served
7.11.5 Guangzhou RiboBio Recent Developments/Updates
7.12 STA Pharmaceutical
7.12.1 STA Pharmaceutical Nucleic Acid Drug Raw Materials Company Information
7.12.2 STA Pharmaceutical Nucleic Acid Drug Raw Materials Product Portfolio
7.12.3 STA Pharmaceutical Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.12.4 STA Pharmaceutical Main Business and Markets Served
7.12.5 STA Pharmaceutical Recent Developments/Updates
7.13 Hongene Biotech
7.13.1 Hongene Biotech Nucleic Acid Drug Raw Materials Company Information
7.13.2 Hongene Biotech Nucleic Acid Drug Raw Materials Product Portfolio
7.13.3 Hongene Biotech Nucleic Acid Drug Raw Materials Production, Value, Price and Gross Margin (2020-2025)
7.13.4 Hongene Biotech Main Business and Markets Served
7.13.5 Hongene Biotech Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Nucleic Acid Drug Raw Materials Industry Chain Analysis
8.2 Nucleic Acid Drug Raw Materials Raw Material Supply Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Nucleic Acid Drug Raw Materials Production Mode & Process Analysis
8.4 Nucleic Acid Drug Raw Materials Sales and Marketing
8.4.1 Nucleic Acid Drug Raw Materials Sales Channels
8.4.2 Nucleic Acid Drug Raw Materials Distributors
8.5 Nucleic Acid Drug Raw Materials Customer Analysis
9 Nucleic Acid Drug Raw Materials Market Dynamics
9.1 Nucleic Acid Drug Raw Materials Industry Trends
9.2 Nucleic Acid Drug Raw Materials Market Drivers
9.3 Nucleic Acid Drug Raw Materials Market Challenges
9.4 Nucleic Acid Drug Raw Materials Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Nucleic Acid Drug Raw Materials Market Value by Type, (US$ Million) & (2024 VS 2031)
 Table 2. Global Nucleic Acid Drug Raw Materials Market Value by Application, (US$ Million) & (2024 VS 2031)
 Table 3. Global Nucleic Acid Drug Raw Materials Production Capacity (Tons) by Manufacturers in 2024
 Table 4. Global Nucleic Acid Drug Raw Materials Production by Manufacturers (2020-2025) & (Tons)
 Table 5. Global Nucleic Acid Drug Raw Materials Production Market Share by Manufacturers (2020-2025)
 Table 6. Global Nucleic Acid Drug Raw Materials Production Value by Manufacturers (2020-2025) & (US$ Million)
 Table 7. Global Nucleic Acid Drug Raw Materials Production Value Share by Manufacturers (2020-2025)
 Table 8. Global Key Players of Nucleic Acid Drug Raw Materials, Industry Ranking, 2023 VS 2024
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Nucleic Acid Drug Raw Materials as of 2024)
 Table 10. Global Market Nucleic Acid Drug Raw Materials Average Price by Manufacturers (US$/Ton) & (2020-2025)
 Table 11. Global Key Manufacturers of Nucleic Acid Drug Raw Materials, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Nucleic Acid Drug Raw Materials, Product Offered and Application
 Table 13. Global Key Manufacturers of Nucleic Acid Drug Raw Materials, Date of Enter into This Industry
 Table 14. Global Nucleic Acid Drug Raw Materials Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Nucleic Acid Drug Raw Materials Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 17. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) by Region (2020-2025)
 Table 18. Global Nucleic Acid Drug Raw Materials Production Value Market Share by Region (2020-2025)
 Table 19. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) Forecast by Region (2026-2031)
 Table 20. Global Nucleic Acid Drug Raw Materials Production Value Market Share Forecast by Region (2026-2031)
 Table 21. Global Nucleic Acid Drug Raw Materials Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 22. Global Nucleic Acid Drug Raw Materials Production (Tons) by Region (2020-2025)
 Table 23. Global Nucleic Acid Drug Raw Materials Production Market Share by Region (2020-2025)
 Table 24. Global Nucleic Acid Drug Raw Materials Production (Tons) Forecast by Region (2026-2031)
 Table 25. Global Nucleic Acid Drug Raw Materials Production Market Share Forecast by Region (2026-2031)
 Table 26. Global Nucleic Acid Drug Raw Materials Market Average Price (US$/Ton) by Region (2020-2025)
 Table 27. Global Nucleic Acid Drug Raw Materials Market Average Price (US$/Ton) by Region (2026-2031)
 Table 28. Global Nucleic Acid Drug Raw Materials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 29. Global Nucleic Acid Drug Raw Materials Consumption by Region (2020-2025) & (Tons)
 Table 30. Global Nucleic Acid Drug Raw Materials Consumption Market Share by Region (2020-2025)
 Table 31. Global Nucleic Acid Drug Raw Materials Forecasted Consumption by Region (2026-2031) & (Tons)
 Table 32. Global Nucleic Acid Drug Raw Materials Forecasted Consumption Market Share by Region (2026-2031)
 Table 33. North America Nucleic Acid Drug Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 34. North America Nucleic Acid Drug Raw Materials Consumption by Country (2020-2025) & (Tons)
 Table 35. North America Nucleic Acid Drug Raw Materials Consumption by Country (2026-2031) & (Tons)
 Table 36. Europe Nucleic Acid Drug Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 37. Europe Nucleic Acid Drug Raw Materials Consumption by Country (2020-2025) & (Tons)
 Table 38. Europe Nucleic Acid Drug Raw Materials Consumption by Country (2026-2031) & (Tons)
 Table 39. Asia Pacific Nucleic Acid Drug Raw Materials Consumption Growth Rate by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 40. Asia Pacific Nucleic Acid Drug Raw Materials Consumption by Region (2020-2025) & (Tons)
 Table 41. Asia Pacific Nucleic Acid Drug Raw Materials Consumption by Region (2026-2031) & (Tons)
 Table 42. Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption Growth Rate by Country: 2020 VS 2024 VS 2031 (Tons)
 Table 43. Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption by Country (2020-2025) & (Tons)
 Table 44. Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption by Country (2026-2031) & (Tons)
 Table 45. Global Nucleic Acid Drug Raw Materials Production (Tons) by Type (2020-2025)
 Table 46. Global Nucleic Acid Drug Raw Materials Production (Tons) by Type (2026-2031)
 Table 47. Global Nucleic Acid Drug Raw Materials Production Market Share by Type (2020-2025)
 Table 48. Global Nucleic Acid Drug Raw Materials Production Market Share by Type (2026-2031)
 Table 49. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) by Type (2020-2025)
 Table 50. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) by Type (2026-2031)
 Table 51. Global Nucleic Acid Drug Raw Materials Production Value Market Share by Type (2020-2025)
 Table 52. Global Nucleic Acid Drug Raw Materials Production Value Market Share by Type (2026-2031)
 Table 53. Global Nucleic Acid Drug Raw Materials Price (US$/Ton) by Type (2020-2025)
 Table 54. Global Nucleic Acid Drug Raw Materials Price (US$/Ton) by Type (2026-2031)
 Table 55. Global Nucleic Acid Drug Raw Materials Production (Tons) by Application (2020-2025)
 Table 56. Global Nucleic Acid Drug Raw Materials Production (Tons) by Application (2026-2031)
 Table 57. Global Nucleic Acid Drug Raw Materials Production Market Share by Application (2020-2025)
 Table 58. Global Nucleic Acid Drug Raw Materials Production Market Share by Application (2026-2031)
 Table 59. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) by Application (2020-2025)
 Table 60. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) by Application (2026-2031)
 Table 61. Global Nucleic Acid Drug Raw Materials Production Value Market Share by Application (2020-2025)
 Table 62. Global Nucleic Acid Drug Raw Materials Production Value Market Share by Application (2026-2031)
 Table 63. Global Nucleic Acid Drug Raw Materials Price (US$/Ton) by Application (2020-2025)
 Table 64. Global Nucleic Acid Drug Raw Materials Price (US$/Ton) by Application (2026-2031)
 Table 65. Danaher Corporation Nucleic Acid Drug Raw Materials Company Information
 Table 66. Danaher Corporation Nucleic Acid Drug Raw Materials Specification and Application
 Table 67. Danaher Corporation Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 68. Danaher Corporation Main Business and Markets Served
 Table 69. Danaher Corporation Recent Developments/Updates
 Table 70. Merck Nucleic Acid Drug Raw Materials Company Information
 Table 71. Merck Nucleic Acid Drug Raw Materials Specification and Application
 Table 72. Merck Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 73. Merck Main Business and Markets Served
 Table 74. Merck Recent Developments/Updates
 Table 75. Eurofins Scientific Nucleic Acid Drug Raw Materials Company Information
 Table 76. Eurofins Scientific Nucleic Acid Drug Raw Materials Specification and Application
 Table 77. Eurofins Scientific Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 78. Eurofins Scientific Main Business and Markets Served
 Table 79. Eurofins Scientific Recent Developments/Updates
 Table 80. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Company Information
 Table 81. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Specification and Application
 Table 82. Thermo Fisher Scientific Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 83. Thermo Fisher Scientific Main Business and Markets Served
 Table 84. Thermo Fisher Scientific Recent Developments/Updates
 Table 85. Agilent Technologies Nucleic Acid Drug Raw Materials Company Information
 Table 86. Agilent Technologies Nucleic Acid Drug Raw Materials Specification and Application
 Table 87. Agilent Technologies Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 88. Agilent Technologies Main Business and Markets Served
 Table 89. Agilent Technologies Recent Developments/Updates
 Table 90. GE Healthcare Nucleic Acid Drug Raw Materials Company Information
 Table 91. GE Healthcare Nucleic Acid Drug Raw Materials Specification and Application
 Table 92. GE Healthcare Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 93. GE Healthcare Main Business and Markets Served
 Table 94. GE Healthcare Recent Developments/Updates
 Table 95. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Company Information
 Table 96. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Specification and Application
 Table 97. Kaneka Eurogentec Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 98. Kaneka Eurogentec Main Business and Markets Served
 Table 99. Kaneka Eurogentec Recent Developments/Updates
 Table 100. GeneDesign Nucleic Acid Drug Raw Materials Company Information
 Table 101. GeneDesign Nucleic Acid Drug Raw Materials Specification and Application
 Table 102. GeneDesign Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 103. GeneDesign Main Business and Markets Served
 Table 104. GeneDesign Recent Developments/Updates
 Table 105. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Company Information
 Table 106. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Specification and Application
 Table 107. LGC Biosearch Technologies Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 108. LGC Biosearch Technologies Main Business and Markets Served
 Table 109. LGC Biosearch Technologies Recent Developments/Updates
 Table 110. Bio-synthesis Nucleic Acid Drug Raw Materials Company Information
 Table 111. Bio-synthesis Nucleic Acid Drug Raw Materials Specification and Application
 Table 112. Bio-synthesis Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 113. Bio-synthesis Main Business and Markets Served
 Table 114. Bio-synthesis Recent Developments/Updates
 Table 115. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Company Information
 Table 116. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Specification and Application
 Table 117. Guangzhou RiboBio Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 118. Guangzhou RiboBio Main Business and Markets Served
 Table 119. Guangzhou RiboBio Recent Developments/Updates
 Table 120. STA Pharmaceutical Nucleic Acid Drug Raw Materials Company Information
 Table 121. STA Pharmaceutical Nucleic Acid Drug Raw Materials Specification and Application
 Table 122. STA Pharmaceutical Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 123. STA Pharmaceutical Main Business and Markets Served
 Table 124. STA Pharmaceutical Recent Developments/Updates
 Table 125. Hongene Biotech Nucleic Acid Drug Raw Materials Company Information
 Table 126. Hongene Biotech Nucleic Acid Drug Raw Materials Specification and Application
 Table 127. Hongene Biotech Nucleic Acid Drug Raw Materials Production (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)
 Table 128. Hongene Biotech Main Business and Markets Served
 Table 129. Hongene Biotech Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Nucleic Acid Drug Raw Materials Distributors List
 Table 133. Nucleic Acid Drug Raw Materials Customers List
 Table 134. Nucleic Acid Drug Raw Materials Market Trends
 Table 135. Nucleic Acid Drug Raw Materials Market Drivers
 Table 136. Nucleic Acid Drug Raw Materials Market Challenges
 Table 137. Nucleic Acid Drug Raw Materials Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Nucleic Acid Drug Raw Materials
 Figure 2. Global Nucleic Acid Drug Raw Materials Market Value by Type, (US$ Million) & (2020-2031)
 Figure 3. Global Nucleic Acid Drug Raw Materials Market Share by Type: 2024 VS 2031
 Figure 4. ASO Product Picture
 Figure 5. siRNA Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Nucleic Acid Drug Raw Materials Market Value by Application, (US$ Million) & (2020-2031)
 Figure 8. Global Nucleic Acid Drug Raw Materials Market Share by Application: 2024 VS 2031
 Figure 9. Research
 Figure 10. Pharmaceutical
 Figure 11. Other
 Figure 12. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Nucleic Acid Drug Raw Materials Production Value (US$ Million) & (2020-2031)
 Figure 14. Global Nucleic Acid Drug Raw Materials Production Capacity (Tons) & (2020-2031)
 Figure 15. Global Nucleic Acid Drug Raw Materials Production (Tons) & (2020-2031)
 Figure 16. Global Nucleic Acid Drug Raw Materials Average Price (US$/Ton) & (2020-2031)
 Figure 17. Nucleic Acid Drug Raw Materials Report Years Considered
 Figure 18. Nucleic Acid Drug Raw Materials Production Share by Manufacturers in 2024
 Figure 19. Global Nucleic Acid Drug Raw Materials Production Value Share by Manufacturers (2024)
 Figure 20. Nucleic Acid Drug Raw Materials Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. The Global 5 and 10 Largest Players: Market Share by Nucleic Acid Drug Raw Materials Revenue in 2024
 Figure 22. Global Nucleic Acid Drug Raw Materials Production Value by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 23. Global Nucleic Acid Drug Raw Materials Production Value Market Share by Region: 2020 VS 2024 VS 2031
 Figure 24. Global Nucleic Acid Drug Raw Materials Production Comparison by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 25. Global Nucleic Acid Drug Raw Materials Production Market Share by Region: 2020 VS 2024 VS 2031
 Figure 26. North America Nucleic Acid Drug Raw Materials Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 27. Europe Nucleic Acid Drug Raw Materials Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 28. China Nucleic Acid Drug Raw Materials Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 29. Japan Nucleic Acid Drug Raw Materials Production Value (US$ Million) Growth Rate (2020-2031)
 Figure 30. Global Nucleic Acid Drug Raw Materials Consumption by Region: 2020 VS 2024 VS 2031 (Tons)
 Figure 31. Global Nucleic Acid Drug Raw Materials Consumption Market Share by Region: 2020 VS 2024 VS 2031
 Figure 32. North America Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 33. North America Nucleic Acid Drug Raw Materials Consumption Market Share by Country (2020-2031)
 Figure 34. U.S. Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 35. Canada Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 36. Europe Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 37. Europe Nucleic Acid Drug Raw Materials Consumption Market Share by Country (2020-2031)
 Figure 38. Germany Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 39. France Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 40. U.K. Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 41. Italy Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 42. Russia Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 43. Asia Pacific Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 44. Asia Pacific Nucleic Acid Drug Raw Materials Consumption Market Share by Region (2020-2031)
 Figure 45. China Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 46. Japan Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 47. South Korea Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 48. China Taiwan Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 49. Southeast Asia Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 50. India Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 51. Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 52. Latin America, Middle East & Africa Nucleic Acid Drug Raw Materials Consumption Market Share by Country (2020-2031)
 Figure 53. Mexico Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 54. Brazil Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 55. Turkey Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 56. GCC Countries Nucleic Acid Drug Raw Materials Consumption and Growth Rate (2020-2031) & (Tons)
 Figure 57. Global Production Market Share of Nucleic Acid Drug Raw Materials by Type (2020-2031)
 Figure 58. Global Production Value Market Share of Nucleic Acid Drug Raw Materials by Type (2020-2031)
 Figure 59. Global Nucleic Acid Drug Raw Materials Price (US$/Ton) by Type (2020-2031)
 Figure 60. Global Production Market Share of Nucleic Acid Drug Raw Materials by Application (2020-2031)
 Figure 61. Global Production Value Market Share of Nucleic Acid Drug Raw Materials by Application (2020-2031)
 Figure 62. Global Nucleic Acid Drug Raw Materials Price (US$/Ton) by Application (2020-2031)
 Figure 63. Nucleic Acid Drug Raw Materials Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

SIMILAR REPORTS